Circular RNA CDK6 suppresses cervical cancer proliferation and metastasis by sponging miR-449a

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Chauhan SR, Bharadwaj M. Gearing up T-cell immunotherapy in cervical cancer. Curr Probl Cancer. 2018;42(2):175–188.
   PubMed Web of Science ®Google Scholar
• Mezei AK, Armstrong HL, Pedersen HN, et al. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review. Int J Cancer. 2017;141(3):437–446.
   PubMed Web of Science ®Google Scholar
• Cervical cancer analysis reveals new mutations. Cancer Discov. 2017;7(4):344.
   Web of Science ®Google Scholar
• Gong J-M, Shen Y, Shan -W-W, et al. The association between MTHFR polymorphism and cervical cancer. Sci Rep. 2018;8(1):7244.
   PubMedGoogle Scholar
• Hyman DM, Piha-Paul SA, Won H, et al. HER kinase inhibition in patients with HER2- and HER3-mutant cancers. Nature. 2018;554(7691):189–194.
   PubMed Web of Science ®Google Scholar
• Matsumoto A, Nakayama KI. Hidden peptides encoded by putative noncoding RNAs. Cell Struct Funct. 2018;43(1):75–83.
   PubMed Web of Science ®Google Scholar
• Chen -L-L, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12(4):381–388.
   PubMed Web of Science ®Google Scholar
• Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: identification, biogenesis and function. Biochimica Et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 2016;1859(1):163–168.
   PubMed Web of Science ®Google Scholar
• Mingyi L, Chenxia L, Huarong Z, et al. CircRNA_0001795 sponges miRNA-339-5p to regulate yes-associated protein 1 expression and attenuate osteoporosis progression. Bioengineered. 2022;13:2803–2815.
   PubMed Web of Science ®Google Scholar
• Song T, Xu A, Zhang Z, et al. CircRNA hsa_circRNA_101996 increases cervical cancer proliferation and invasion through activating TPX2 expression by restraining miR-8075. J Cell Physiol. 2019;234(8):14296–14305.
   PubMed Web of Science ®Google Scholar
• Lanfang F, Juyun Z, Zhu L, et al. CircularRNA circ_0071269 knockdown protects against from diabetic cardiomyopathy injury by microRNA-145/gasdermin A axis. Bioengineered. 2022;13:2398–2411.
   PubMed Web of Science ®Google Scholar
• Hong-Bo Z, Xiang-Ming Q, Yi-Chao Z, et al. Circ_0017639 facilitates proliferative, migratory, and invasive potential of non-small cell lung cancer (NSCLC) cells via PI3K/AKT signaling pathway. Bioengineered. 2022;13:1590–1601.
   PubMed Web of Science ®Google Scholar
• Lipeng W, Shaozhang H, Jianning L, et al. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis. Bioengineered. 2022;13:1209–1223.
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–355.
   PubMed Web of Science ®Google Scholar
• Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3–14.
   PubMed Web of Science ®Google Scholar
• Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42–51.
   PubMed Web of Science ®Google Scholar
• Lv D, Zhen Z, Huang D. MicroRNA-432 is downregulated in osteosarcoma and inhibits cell proliferation and invasion by directly targeting metastasis-associated in colon cancer-1. Exp Ther Med. 2019;17(1):919–926.
   PubMed Web of Science ®Google Scholar
• Liu F, Cai Y, Rong X, et al. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer. Mol Cancer. 2017;16(1):122.
   PubMedGoogle Scholar
• Li J, Lu M, Jin J, et al. miR-449a suppresses tamoxifen resistance in human breast cancer cells by targeting ADAM22. Cell Physiol Biochem. 2018;50(1):136–149.
   PubMedGoogle Scholar
• Zhang N, Qiu L, Li T, et al. MiR-449a attenuates autophagy of T-cell lymphoma cells by downregulating ATG4B expression. BMB Rep. 2020;53:254–259.
   PubMed Web of Science ®Google Scholar
• Ishikawa D, Yoshikawa K, Takasu C, et al. Expression level of MicroRNA-449a predicts the prognosis of patients with gastric cancer. Anticancer Res. 2020;40(1):239–244.
   PubMed Web of Science ®Google Scholar
• Jinxin C, Xiaocen L, Yang L, et al. CircASH2L promotes ovarian cancer tumorigenesis, angiogenesis, and lymphangiogenesis by regulating the miR-665/VEGFA axis as a competing endogenous RNA. Front Cell Dev Biol. 2020;8:595585.
   PubMed Web of Science ®Google Scholar
• Yanan Z, Zhao L, Shizhou Y, et al. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression. J Exp Clin Cancer Res. 2020;39:281.
   PubMed Web of Science ®Google Scholar
• Yang JX, Rastetter RH, Wilhelm D. Non-coding RNAs: an Introduction. Adv Exp Med Biol. 2016;886:13–32.
   PubMed Web of Science ®Google Scholar
• Greene J, Baird AM, Brady L, et al. Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci. 2017;4:38.
   PubMed Web of Science ®Google Scholar
• Huang P, Qi B, Yao H, et al. Circular RNA cSMARCA5 regulates the progression of cervical cancer by acting as a microRNA432 sponge. Mol Med Rep. 2020;21(3):1217–1223.
   PubMed Web of Science ®Google Scholar
• Qian W, Huang T, Feng W. Circular RNA HIPK3 promotes EMT of cervical cancer through sponging miR-338-3p to up-regulate HIF-1alpha. Cancer Manag Res. 2020;12:177–187.
   PubMed Web of Science ®Google Scholar
• Chen T, You Y, Jiang H, et al. Epithelial-mesenchymal transition (EMT): a biological process in the development, stem cell differentiation, and tumorigenesis. J Cell Physiol. 2017;232(12):3261–3272.
   PubMed Web of Science ®Google Scholar
• Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. BCR. 2001;3(5):289–293.
   PubMed Web of Science ®Google Scholar
• Mrozik KM, Blaschuk OW, Cheong CM, et al. N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer. BMC Cancer. 2018;18(1):939.
   PubMedGoogle Scholar
• Cavallaro U. N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr Opin Invest Drugs. 2004;5(12):1274–1278.
   PubMedGoogle Scholar
• Wang L, Zhao Y, Xiong W, et al. MicroRNA-449a is downregulated in cervical cancer and inhibits proliferation, migration, and invasion. Oncol Res Treat. 2019;42(11):564–571.
   PubMed Web of Science ®Google Scholar